SIK2 Is a Centrosome Kinase Required for Bipolar Mitotic Spindle Formation that Provides a Potential Target for Therapy in Ovarian Cancer

被引:122
作者
Ahmed, Ahmed Ashour [1 ,4 ,5 ]
Lu, Zhen [1 ]
Jennings, Nicholas B. [2 ]
Etemadmoghadam, Dariush [7 ]
Capalbo, Luisa [6 ]
Jacamo, Rodrigo O. [3 ]
Barbosa-Morais, Nuno [8 ]
Le, Xiao-Feng [1 ]
Vivas-Mejia, Pablo [1 ]
Lopez-Berestein, Gabriel [1 ]
Grandjean, Geoffrey [1 ]
Bartholomeusz, Geoffrey [1 ]
Liao, Warren [1 ]
Andreeff, Michael [3 ]
Bowtell, David [7 ]
Glover, David M. [6 ]
Sood, Anil K. [2 ]
Bast, Robert C., Jr. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[4] Univ Cambridge, Hutchison MRC Res Ctr, Dept Oncol, Cambridge CB2 0XZ, England
[5] Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge CB2 0SW, England
[6] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England
[7] Peter MacCallum Canc Ctr, Canc Genom & Genet Lab, Melbourne, Vic 8006, Australia
[8] Univ Cambridge, Canc Res UK Cambridge Res Inst, Dept Oncol, Computat Biol Grp,Li Ka Shing Ctr, Cambridge CB2 0RE, England
基金
英国医学研究理事会;
关键词
CELL-CYCLE PROGRESSION; ALPHA REGULATORY SUBUNIT; COACTIVATOR TORC2; PROTEIN-KINASE; RII-ALPHA; S-PHASE; PACLITAXEL; CREB; CYCLOPHOSPHAMIDE; PHOSPHORYLATION;
D O I
10.1016/j.ccr.2010.06.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Regulators of mitosis have been successfully targeted to enhance response to taxane chemotherapy. Here, we show that the salt inducible kinase 2 (SIK2) localizes at the centrosome, plays a key role in the initiation of mitosis, and regulates the localization of the centrosome linker protein, C-Nap1, through S2392 phosphorylation. Interference with the known SIK2 inhibitor PKA induced SIK2-dependent centrosome splitting in interphase while SIK2 depletion blocked centrosome separation in mitosis, sensitizing ovarian cancers to paclitaxel in culture and in xenografts. Depletion of SIK2 also delayed G1/S transition and reduced AKT phosphorylation. Higher expression of SIK2 significantly correlated with poor survival in patients with high-grade serous ovarian cancers. We believe these data identify SIK2 as a plausible target for therapy in ovarian cancers.
引用
收藏
页码:109 / 121
页数:13
相关论文
共 32 条
[1]   The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel [J].
Ahmed, Ahmed Ashour ;
Mills, Anthony D. ;
Ibrahim, Ashraf E. K. ;
Temple, Jillian ;
Blenkiron, Cherie ;
Vias, Maria ;
Massie, Charlie E. ;
Iyer, N. Gopalakrishna ;
McGeoch, Adam ;
Crawford, Robin ;
Nicke, Barbara ;
Downward, Julian ;
Swanton, Charles ;
Bell, Stephen D. ;
Earl, Helena M. ;
Laskey, Ronald A. ;
Caldas, Carlos ;
Brenton, James D. .
CANCER CELL, 2007, 12 (06) :514-527
[2]   Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit [J].
Bekier, Michael E. ;
Fischbach, Robert ;
Lee, Jennifer ;
Taylor, William R. .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (06) :1646-1654
[3]   Genome-wide survey of protein kinases required for cell cycle progression [J].
Bettencourt-Dias, M ;
Giet, R ;
Sinka, R ;
Mazumdar, A ;
Lock, WG ;
Balloux, F ;
Zafiropoulos, PJ ;
Yamaguchi, S ;
Winter, S ;
Carthew, RW ;
Cooper, M ;
Jones, D ;
Frenz, L ;
Glover, DM .
NATURE, 2004, 432 (7020) :980-987
[4]   A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours [J].
Blagden, S. P. ;
Molife, L. R. ;
Seebaran, A. ;
Payne, M. ;
Reid, A. H. M. ;
Protheroe, A. S. ;
Vasist, L. S. ;
Williams, D. D. ;
Bowen, C. ;
Kathman, S. J. ;
Hodge, J. P. ;
Dar, M. M. ;
de Bono, J. S. ;
Middleton, M. R. .
BRITISH JOURNAL OF CANCER, 2008, 98 (05) :894-899
[5]  
Carlson CR, 2001, J CELL SCI, V114, P3243
[6]  
de Castro I.Perez., 2008, CURR OPIN PHARMACOL, V8, P375, DOI DOI 10.1016/j.coph.2008.06.013
[7]   Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2 [J].
Dentin, Renaud ;
Liu, Yi ;
Koo, Seung-Hoi ;
Hedrick, Susan ;
Vargas, Thomas ;
Heredia, Jose ;
Yates, John, III ;
Montminy, Marc .
NATURE, 2007, 449 (7160) :366-+
[8]   C-Nap1, a novel centrosomal coiled-coil protein and candidate substrate of the cell cycle-regulated protein kinase Nek2 [J].
Fry, AM ;
Mayor, T ;
Meraldi, P ;
Stierhof, YD ;
Tanaka, K ;
Nigg, EA .
JOURNAL OF CELL BIOLOGY, 1998, 141 (07) :1563-1574
[9]   A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators [J].
Fry, AM ;
Meraldi, P ;
Nigg, EA .
EMBO JOURNAL, 1998, 17 (02) :470-481
[10]   Aurora kinases as anticancer drug targets [J].
Gautschi, Oliver ;
Heighway, Jim ;
Mack, Philip C. ;
Purnell, Phillip R. ;
Lara, Primo N., Jr. ;
Gandara, David R. .
CLINICAL CANCER RESEARCH, 2008, 14 (06) :1639-1648